Drugmaker Abbott Laboratories, knocking down a report in the Financial Times, denied on Thursday that it was preparing a bid for medical device maker St Jude Medical Inc. The FT, citing people familiar with the matter, reported that Abbott has been working with advisers for several weeks to line up financing for a $25 billion cash and stock bid for St. Paul, Minnesota-based St Jude.
The new Trump administration and Republican Congress – and all the accompanying change and uncertainty – is the major story for the medical device industry. […]
Board certified orthopaedic surgeon Gregory M. Martin, MD performs more total knee replacements than any other operation at his Boynton Beach, Florida, practice. Over the years, he began to realize he could do a great […]
There’s been a lot of hype around 3D printing, but its applications in medicine are real. Advances in “additive manufacturing” — the industrial version of 3D printing — are being applied toward federally approved medical […]